Celldex Therapeutics, Inc.
CLDX
$41.95
-$0.66-1.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -73.50M | -78.69M | -81.32M | -67.04M | -56.60M |
| Total Depreciation and Amortization | 902.00K | 854.00K | 816.00K | 824.00K | 873.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.71M | 7.90M | 8.03M | 7.79M | 7.51M |
| Change in Net Operating Assets | 8.48M | 4.35M | 8.53M | 9.80M | 4.22M |
| Cash from Operations | -57.41M | -65.59M | -63.94M | -48.63M | -44.01M |
| Capital Expenditure | -3.18M | -1.64M | -1.28M | -440.00K | -728.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -252.34M | 73.76M | 56.71M | 61.29M | 50.58M |
| Cash from Investing | -255.52M | 72.12M | 55.43M | 60.85M | 49.85M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 324.66M | 327.00K | 1.35M | 774.00K | 63.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 324.66M | 327.00K | 1.35M | 774.00K | 63.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.73M | 6.86M | -7.17M | 12.99M | 5.91M |